The Glycosylation of the Complement Regulatory Protein, Human Erythrocyte CD59 *
Journal of Biological Chemistry, ISSN: 0021-9258, Vol: 272, Issue: 11, Page: 7229-7244
1997
- 139Citations
- 59Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations139
- Citation Indexes139
- 139
- CrossRef132
- Captures59
- Readers59
- 59
Article Description
Human erythrocyte CD59 contains N - and O -glycans and a glycosylphosphatidylinositol (GPI) anchor, all of which have been analyzed in this study. The anchor consists principally of the minimum core glycan sequence Manα1-2Manα1-6Manα1-4GlcN-linked to a phosphatidylinositol moiety with the structure sn -1- O -alkyl(C18:0 and C18:1)-2- O -acyl(C20:4)glycerol-3-phospho-1-(2- O -palmitoyl(C16:0)) myo -inositol. This structure is essentially identical to that of human erythrocyte cholinesterase (Deeg, M. A., Humphrey, D. R., Yang, S. H., Ferguson, T. R., Reinhold, V. N., and Rosenberry, T. L. (1992) J. Biol. Chem. 267, 18573-18580). This first comparison of GPI anchors from different proteins expressed in the same tissue suggests that human reticulocytes produce only one type of anchor structure. The N - and O -glycans were sequenced using a novel approach involving digestion of the total glycan pool with multiple enzyme arrays. The N -glycan pool contained families of bi-antennary complex-type structures with and without lactosamine extensions and outer arm fucose residues. The predominant O -glycans were NeuNAcα2-3Galβ1-3GalNAc and Galβ1-3[NeuNAcα2-3]GalNAc. Inspection of a molecular model of CD59, based on the NMR solution structure of the extracellular domain and the structural data from this study, suggested several roles for the glycans, including spacing and orienting CD59 on the cell surface and protecting the molecule from proteases. This work completes the initial structural analysis of CD59, providing the most complete view of any cell surface glycoprotein studied to date.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0021925818410605; http://dx.doi.org/10.1074/jbc.272.11.7229; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0031003042&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9054419; https://linkinghub.elsevier.com/retrieve/pii/S0021925818410605; https://dx.doi.org/10.1074/jbc.272.11.7229
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know